B. Riley Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

B. Riley Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$214K	Buy	+9,689	New	+$176K	0.01%	1018
2016 Q2	–	Sell	-4,887	Closed	-$261K	–	647
2016 Q1	$261K	Sell	4,887 -107	-2%	-$6.28K	0.06%	389
2015 Q4	$329K	Buy	+4,994	New	+$309K	0.07%	341
2015 Q1	–	Sell	-3,360	Closed	-$193	–	1840
2014 Q4	$193	Sell	3,360 -580	-15%	-$32.3K	﹤0.01%	1398
2014 Q3	$212K	Sell	3,940 -5,186	-57%	-$275K	0.06%	493
2014 Q2	$245K	Buy	9,126 +4,333	+90%	+$221K	0.06%	381
2014 Q1	$253K	Sell	4,793 -2,579	-35%	-$119K	0.08%	308
2013 Q4	$295K	Buy	+7,372	New	+$290K	0.09%	245

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

B. Riley Wealth Advisors's TEVA Position: Q4 2024 in Review

B. Riley Wealth Advisors opened a new position in Teva Pharmaceuticals (TEVA) in Q4 2024: 9,689 shares worth $214K. The stake represents 0.01% of the portfolio and ranks #1018 among its holdings. This is a return to the name: B. Riley Wealth Advisors previously reported a position in TEVA as recently as Q1 2016.

B. Riley Wealth Advisors first reported a position in TEVA in Q4 2013 and has held it in 8 quarters since. The position peaked at $329K in Q4 2015. 583 funds tracked by Wall St. Rank hold TEVA as of Q4 2024.

B. Riley Wealth Advisors held 9,689 shares of Teva Pharmaceuticals worth $214K as of Q4 2024.
Teva Pharmaceuticals was a new B. Riley Wealth Advisors position in Q4 2024.
Teva Pharmaceuticals made up 0.01% of B. Riley Wealth Advisors's portfolio in Q4 2024, its #1018 holding.
B. Riley Wealth Advisors first reported a position in Teva Pharmaceuticals in Q4 2013 and has held it in 8 quarters since.
B. Riley Wealth Advisors's Teva Pharmaceuticals position peaked at $329K in Q4 2015.
583 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2024.

Based on B. Riley Wealth Advisors's 13F filing for Q4 2024, filed 25 Feb 2025.